MedTrace Logo

Laughter Yoga, Emotional Labor, and Menopause-Specific Quality of Life in Nurses

NCT07738211 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-07-31

No results posted yet for this study

Summary

This randomized controlled trial aimed to evaluate the effects of laughter yoga on emotional labor behavior and menopause-specific quality of life among menopausal nurses. A total of 120 premenopausal and postmenopausal nurses were randomly assigned to an intervention group (n=60) or a control group (n=60). The intervention group participated in eight laughter yoga sessions over four weeks, while the control group received no intervention. Emotional labor behavior and menopause-specific quality of life were assessed at baseline, post-intervention, and follow-up using validated instruments. The primary objective was to determine whether laughter yoga improves emotional labor behavior and menopause-specific quality of life compared with usual practice.

Conditions

  • Menopause
  • Menopause-Related Quality of Life
  • Emotional Labor
  • Nurse

Interventions

BEHAVIORAL

Laughter Yoga

Participants assigned to the intervention group received laughter yoga in groups of 10-12 participants. The intervention consisted of eight sessions conducted over four weeks (two sessions per week), with each session lasting approximately 30-40 minutes. Sessions included warm-up exercises, rhythmic clapping, deep breathing techniques, playful activities, simulated laughter exercises, and laughter meditation, followed by relaxation. All sessions were conducted face-to-face by a certified laughter yoga instructor according to the standard laughter yoga protocol.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Yurdagül Yağmur · Inonu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-25
Primary Completion
2026-07-25
Completion
2026-11-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07738211 on ClinicalTrials.gov